273 assets in Metastatic Malignant Neoplasm

Therapeutic assets addressing Metastatic Malignant Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
npx267 Metastatic Malignant Neoplasm	NextPoint Therapeutics, Inc.	P1	CC (43)
npx887 Metastatic Malignant Neoplasm	NextPoint Therapeutics, Inc.	P1	CC (43)
nw-101c Metastatic Malignant Neoplasm	Neowise Biotechnology	P1	CC (43)
or502 Metastatic Malignant Neoplasm	OncoResponse, Inc.	P1/2	CC (43)
prg2505 Metastatic Malignant Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (43)
Psma I&T Metastatic Malignant Neoplasm	CHU de Quebec-Universite Laval	P1/2	CC (43)
q901 Metastatic Malignant Neoplasm	Qurient Co., Ltd.	P1/2	CC (43)
qh101 Metastatic Malignant Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (43)
qlc5513 Metastatic Malignant Neoplasm	Qilu Pharmaceutical Co., Ltd.	P1/2	CC (43)
Recombinant Humanized Bispecific Monoclonal Antibody Mbs301 Metastatic Malignant Neoplasm	Beijing Mabworks Biotech Co., Ltd.	P1	CC (43)
Repotrectinib Metastatic Malignant Neoplasm	Turning Point Therapeutics, Inc.	P1/2	CC (43)
Rezatapopt Metastatic Malignant Neoplasm	PMV Pharmaceuticals, Inc	P1/2	CC (43)
Solnerstotug Metastatic Malignant Neoplasm	Sensei Biotherapeutics, Inc.	P1/2	CC (43)
sys6043 Metastatic Malignant Neoplasm	Conjupro Biotherapeutics, Inc.	P1	CC (43)
Taest1901 Metastatic Malignant Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (43)
Tc-N201 Metastatic Malignant Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (43)
Tipiracil Metastatic Malignant Neoplasm	Parabilis Medicines, Inc.	P1/2	CC (43)
Trifluridine Metastatic Malignant Neoplasm	Parabilis Medicines, Inc.	P1/2	CC (43)
Vsv Metastatic Malignant Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (43)
xon7 Metastatic Malignant Neoplasm	Xenothera SAS	P1/2	CC (43)
yl-201 Metastatic Malignant Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (43)
Ysch-01 Metastatic Malignant Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (43)
Zoldonrasib Metastatic Malignant Neoplasm	Revolution Medicines, Inc.	P1/2	CC (43)
Zovostotug Metastatic Malignant Neoplasm	OncoResponse, Inc.	P1/2	CC (43)
art4215 Metastatic Malignant Neoplasm	Artios Pharma Ltd	P1	CC (42)
Bendamustine Metastatic Malignant Neoplasm	Fred Hutchinson Cancer Center	P1	CC (42)
CD47/SIRPA-BLOCKING AGENT ALX148 Metastatic Malignant Neoplasm	QuantumLeap Healthcare Collaborative	P1	CC (42)
Dostarlimab Metastatic Malignant Neoplasm	University of Washington	P1	CC (42)
Hmbd-002 Metastatic Malignant Neoplasm	Hummingbird Bioscience	P1	CC (42)
Jskn003 Metastatic Malignant Neoplasm	Alphamab (Australia) Co Pty Ltd.	P1	CC (42)
Migoprotafib Metastatic Malignant Neoplasm	Genentech, Inc.	P1	CC (42)
Omeprazole Metastatic Malignant Neoplasm	Genentech, Inc.	P1	CC (42)
snk02 Metastatic Malignant Neoplasm	NKGen Biotech, Inc.	P1	CC (42)
Utomilumab Metastatic Malignant Neoplasm	M.D. Anderson Cancer Center	P1/2	CC (42)
Ziv-Aflibercept Metastatic Malignant Neoplasm	National Cancer Institute (NCI)	P1	CC (42)
Camonsertib Metastatic Malignant Neoplasm	Memorial Sloan Kettering Cancer Center	P1/2	CC (41)
[18f]csb-321 Metastatic Malignant Neoplasm	Cytosite Biopharma Inc.	P1	C (39)
18f-trx Metastatic Malignant Neoplasm	Rahul Aggarwal	P1	C (39)
5P12-RANTES Metastatic Malignant Neoplasm	Orion Biotechnology Polska Sp. z o.o.	P1	C (39)
Adcx-020 Metastatic Malignant Neoplasm	Adcytherix SAS	P1	C (39)
Albamycin Metastatic Malignant Neoplasm	National Cancer Institute (NCI)	P1	C (39)
Alta2618 Metastatic Malignant Neoplasm	Alterome Therapeutics, Inc.	P1	C (39)
Autologous Anti-Cd19 Car-Expressing T Lymphocytes Metastatic Malignant Neoplasm	Anusha Kalbasi	P1	C (39)
Axitinib Metastatic Malignant Neoplasm	M.D. Anderson Cancer Center	P1	C (39)
azd1390 Metastatic Malignant Neoplasm	Memorial Sloan Kettering Cancer Center	P1	C (39)
Azenosertib Metastatic Malignant Neoplasm	National Cancer Institute (NCI)	P1	C (39)
Bgb-53038 Metastatic Malignant Neoplasm	BeOne Medicines	P1	C (39)
Bgb-B3227 Metastatic Malignant Neoplasm	BeiGene	P1	C (39)
Bpi-421286 Metastatic Malignant Neoplasm	Betta Pharmaceuticals Co., Ltd.	P1	C (39)
Budigalimab Metastatic Malignant Neoplasm	AbbVie	P1	C (39)

Showing 151 to 200 of 273 assets

PreviousPage 4 of 6Next